Genomic Prediction
2 known investors
LifeView provides preimplantation genetic testing for IVF embryos, including screening for chromosomal abnormalities (PGT-A/A+), single-gene disorders (PGT-M), structural rearrangements (PGT-SR), and its Embryo Health Score polygenic risk test. Its services target prospective parents and fertility clinics seeking to improve IVF success rates and reduce miscarriage and genetic disease risk.
BiotechDigital HealthFemTech
Investors · 2
Frequently asked questions
- What does Genomic Prediction do?
- LifeView provides preimplantation genetic testing for IVF embryos, including screening for chromosomal abnormalities (PGT-A/A+), single-gene disorders (PGT-M), structural rearrangements (PGT-SR), and its Embryo Health Score polygenic risk test. Its services target prospective parents and fertility clinics seeking to improve IVF success rates and reduce miscarriage and genetic disease risk.
- Who are Genomic Prediction's investors?
- Genomic Prediction's investors include AAF Management Ltd., Metaplanet.